Tower Research Capital (TRC)’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Tower Research Capital (TRC)’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,801	Closed	-$18K	–	6810
2022 Q3	$18K	Buy	1,801 +1	+0.1%	+$10	﹤0.01%	4048
2022 Q2	$18K	Sell	1,800 -6	-0.3%	-$59	﹤0.01%	3934
2022 Q1	$18K	Buy	+1,806	New	+$17.6K	﹤0.01%	3663

Tower Research Capital (TRC)'s SHAC Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 1,801 shares — an estimated $18K sold.

Tower Research Capital (TRC) first reported a position in SHAC in Q1 2022 and held it in 3 quarters. The position peaked at $18K in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Tower Research Capital (TRC) reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 1,801 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $18K.
Tower Research Capital (TRC) first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2022 and held it in 3 quarters.
Tower Research Capital (TRC)'s SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $18K in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.